Dr. Amy’s Resume

Amy A. Yasko,



  • Doctorate Microbiology/Immunology/Infectious Disease
  • Certified Alternative Medical Practitioner
  • Certified Holistic Health Practitioner
  • Fellow-American Association Integrative Medicine
  • College of Physicians-Certified Diplomat
  • College of Herbal Medicine-Certified Diplomat
  • College of Pharmaceutical Sciences-Certified Diplomat


Albany Medical College of Union University

  • Microbiology/Immunology & Infectious Disease; Ph.D. – graduated Summa Cum Laude
  • Research – Antibiotic Resistance and Transport; Dean’s Award for Research Excellence
  • Cytochromes and Antibiotic Resistance

Clayton College of Natural Health

  • Doctor Naturopathy; Graduated with Highest Honors
  • NHD – Doctor Natural Health; Graduated with Highest honors

Colgate University

  • Double Major – Chemistry and Fine Arts
  • B.A. – Graduated Magna Cum Laude

Academic Positions

  • Yale Medical Center
    Department of Hematology
    New Haven, Connecticut
    Fellow – Eukaryotic/Prokaryotic Shuttle Vectors
  • Strong Memorial Hospital
    Cancer Center
    Rochester, New York
    Fellow – Mammalian Retroviruses
  • Strong Memorial Hospital
    Dept. Pediatrics & Infectious Disease
    Rochester, New York
    Fellow – Bacterial Vaccines

Industrial Positions

  • Neurological Research Institute, LLC
    Complementary & Alternative Health Care
  • Holistic Health Consultants, LLC
    Scientific Consultant
    Complementary & Alternative Health Care
  • Oligos Etc. Inc.
    Cofounder and Vice President
    Synthesis and Development of Nucleic Acid based drugs
    as anti-microbial and anti-inflammatory agents
  • Biotix Inc.
    Cofounder and Vice President
    Development of automated DNA Synthesizer
  • International Biotechnologies Inc. (now Kodak/IBI)
    Director of Research and Development
    Development of Molecular Biology Kits

Honors and Associations

  • 2004 CASD Award for RNA Research in Autism
  • Who’s Who in the World
  • Who’s Who in American Women
  • Who’s Who in Science and Engineering
  • Who’s Who in Young Professionals
  • Who’s Who in Emerging Leaders
  • Scientific Advisory Board-National Foundation Alternative Medicine (NFAM)
  • American College for Advancement in Medicine
  • Founding Member of National Integrative Medicine Council (NIMC)
  • American Naturopathic Medical Association
  • Society for Neuroscience
  • American Nutraceutical Association
  • Association of Drugless Practitioners
  • National Center for Homeopathy
  • American Association of Pharmaceutical Scientists
  • Marion Foundation
  • Association of Medical Diagnostics Manufacturers
  • American Chemical Society – Division of Medicinal Chemistry
  • American Society for Microbiology
  • Life Extension Foundation
  • New York Biotechnology Association
  • New York Academy of Sciences
  • American Association for the Advancement of Science
  • National Association of Female Executives
  • Sigma XI Research Society

Publications, Interviews & Presentations

  1. Yasko, A and N. Mullan. (2015) Feel Good Biochemistry. Neurological Research Institute, Bethel Maine
  2. Yasko, A. (2014) Roadmap to Health in Autism: What the Experts Know Resource Booklet, 4th
  3. Yasko, A. (2014) Feel Good Nutrigenomics. Neurological Research Institute, Bethel Maine
  4. Yasko, Amy. (2013) Interview with Eva Herr. Infinite Consciousness.1 September 2013.
  5. Yasko, A. (2013). Simplified Roadmap to Health.
  6. Yasko, A.(2013) Methylation, Genetics and Diagnostics in Diagnostic Testing and Functional Medicine by Ameer Rosic.
  7. Mullan, N. and A.Yasko. (2013). Aluminum Toxicity in Mitochondrial Dysfunction and ASD. Autism Science Digest, Issue 05.
  8. Yasko, A. (2013) Using Nutrigenomics to Optimize Supplement Choices in Cutting Edge Therapies for Autism by Siri and Lyons. Chapter 20.
  9. Yasko, A. (2012) NRI Autism Conference, Portland, ME
  10. Yasko, A and N.Mullan. (2012). Gastrointestinal Balance and Neurotransmitter Formation. Autism Science Digest, Issue 04 July.
  11. Mullan, N and A. Yasko (2012). Demystifying Genes: Your Child’s Most Important Biochemistry. Autism Science Digest, Issue 03.
  12. Yasko, A. (2011) NRI Autism Conference, Los Angeles, CA
  13. Mullan, N and A.Yasko (2011) Methionine and Methylation: Chicken or the Egg. Autism Science Digest. Issue 1 April.
  14. Yasko, A. (2011) Role of H.Pylori in Autism & Professional Training Session at AutismOne Chicago, IL
  15. Yasko, A. and N.Mullan (2010). How Bacterial Imbalances May Predispose to Seizure Disorder. Autism File. Issue 38
  16. Yasko, A. (2010) NRI Autism Conference, Boston, MA
  17. Yasko, Amy. (2010) Interview with Eva Herr. Infinite Consciousness.14 February 2010.
  18. Yasko, A. (2009) Autism: Pathways to Recovery. Neurological Research Institute, Bethel Maine
  19. Yasko, A (2009) Assessment of Metals & Microbes in Autism & Professional Training Session Autism One Conference, Chicago, IL
  20. Yasko, A. (2008) Interview with Jill Neimark in Curing the Children of Silent Spring. Spirituality and Health January 2008.
  21. Yasko A. (2008) Individualized Approach to Autism lecture at AutismOne Chicago
  22. Yasko, A (2007) Interviewee with Jill Neimark in Autism: It’s Not Just in the Head. Discover Magazine March 2007.
  23. Yasko, A. (2006) Interviewee, Autism Film Premier, Finding the Words San Francisco CA
  24. Yasko, A. (2006) Beyond Autism Conference Boston MA
  25. Yasko, Amy. (2006) Interview with Teri Small. Autism: Help, Hope, and Healing.  Autism One Radio. IL. 25 July 2006, 1 Aug. 2006.
  26. Yasko, Amy. (2006) Interview with Burton Goldberg. Do No Harm.
  27. Yasko, A. (2006) A Comprehensive Analysis of Autism: From Metals to Mutations Conference Phoenix AZ
  28. Yasko, A. and G. Gordon (2006) Nutrigenomic Testing and the Methylation Pathway. Townsend Newsletter. 270: 69.
  29. Yasko, A. and G. Gordon (2006) The Puzzle of Autism. Revised Ed. Matrix Press.
  30. Yasko, A. (2005) Genetic Bypass: Using Nutriton to Bypass Genetic Mutations. Matrix Publishing NY, NY.
  31. Yasko, A. (2005) The Role of RNA in Addressing Multifactorial Disease. Annals Fourth Stromboli Conference on Aging and Cancer.
  32. Yasko, A (2005) Speaker, ACAM Alternative Medical Conference Anaheim, CA
  33. Yasko, A (2005) Speaker, NDHM Autism Conference Scottsdale, AZ
  34. Yasko, A. (2005) Speaker, Stromboli Conference Cancer/Antiaging Stromboli, Italy
  35. Yasko, A. and G. Gordon (2005) A Mutifactorial Approach to Heart Disease. Townsend Newsletter, May 2005.
  36. Yasko, Amy. (2005) Interview with Deborah Ray. The Deborah Ray Show. Healthy Talk Radio. FL. 12 May 2005.
  37. Yasko, Amy. (2005) Interview with Dr. Majid Ali. Science, Health, Healing. WBAI, NY. 9 May 2005.
  38. Yasko, A. (2005) Speaker, ACAM, Alternative Medical Conference Orlando, FL
  39. Yasko, Amy. (2005) Interview with Dr. Dennis Courtney. AM Impact on Your Health. WKHB, PA. 21 Mar. 2005, 23 Mar. 2005, 30 Mar. 2005.
  40. Yasko, Amy. (2005) Interview with Burton Goldberg. Health News. WBAI, NY. 2 Mar. 2005.
  41. Yasko, Amy. Interview with Elizabeth Nelson. Finding the Words. 2005. PBS.
  42. Yasko, A. (2004) Speaker, CASD Autism Conference Austin, TX
  43. Yasko, A. and G. Gordon (2004) Heal Your Body Naturally. Explore 13(6).
  44. Gordon, G. and A. Yasko (2004) A Unique Approach to Metal Detoxification. Explore 13(5).
  45. Gordon, G. and A. Yasko (2004) RNA Based Therapies in Nutritional Medicine. Explore 13(2).
  46. Yasko, A. (2003).Speaker, New Dimensions in Medicine & Health. Phoenix, AZ
  47. Yasko, A. (2003) Autism: An Approach to Reversing the Process.
  48. Yasko, A. (2003) Neurological Inflammation: An Approach to Reversing the Process.
  49. Yasko, A. (2002) Speaker, NFAM, Alternative Medical Conference Washington , DC
  50. Yasko, A. (2002) Role of Excitotoxins in Autistic Type Behavior.
  51. Bates, Reddoch, Hansakul, Arrow(Yasko), Dale, Miller. (2002) Biosensor detection of triplex formation by modified oligonucleotides. Anal Biochem. 15; 307(2):235-43.
  52. Dale, RMK, Amy Arrow (Yasko), Woolf, Thompson, Gatton. (1996) On the Quality Control of Antisense Oligonucleotides. Antisense and Nucleic Acid Drug Development. 6 (3):151.
  53. Dale, RMK Amy Arrow (Yasko), Terry Thompson. Oligonucleotide- Containing Pharmacological Compositions and Their Use. US Patent number: 8188259, Patent number: 8183361
  54. Dale, RMK, Amy Arrow (Yasko), Steve Gatton, Terry Thompson. Protonated/acidified nucleic acids and methods of use. US Patent number: 6211349
  55. Dale, RMK, Steve Gatton, Amy Arrow (Yasko), A. Pulmonary delivery of protonated/acidified nucleic acids. Patent number: 6211162
  56. Dale, RMK, Gatton, Arrow (Yasko), A. Devices for Improved Wound Management. Patent number: 8435960, Patent number: 6627215
  57. Arrow (Yasko), A., Dale, Thompson. Therapeutic Antisense Phosphodiesterase Inhibitors. US Patent Application number: 20030045490
  58. Woolf, Tod, Amy Arrow (Yasko), RMK Dale. Three Component Chimeric Antisense Oligonucleotides. US Patent number: 7691996, Patent number: 6958239
  59. Arrow (Yasko), A. RMK Dale, S. Raza, S. Srivastava. Oligonucleotide phosphate esters. US Patent number: 6015886
  60. Arrow (Yasko), A., S.Gatton, RMK Dale, T. Thompson. Antimicrobial Compounds and their use. US Patent number: 7176191
  61. Dale, RMK and Amy Arrow (Yasko). (1989) A rapid single stranded cloning sequencing, insertion, and deletion strategy. Recombinant DNA Methodology, p.711    Editors: Wu. Grossman, Moldave. Academic Press, NY.
  62. Henderson, M., Arrow (Yasko), A. Dale, RMK. (1989) Rapid Synthesis, cleavage, and deprotection of DNA sequencing primers. American Biotechnology Laboratory 7 (3): 20.
  63. Henderson, M., Arrow (Yasko), A., Dale, RMK. (1989) Chemical integrity and biological activity of synthetic DNA. American Biotechnology Laboratory 7 (6):22.
  64. Dale, RMK and Amy Arrow (Yasko). (1987) A rapid single stranded cloning sequencing, insertion and deletion strategy. In: Methods in Enzymology 204:155.
  65. Arrow (Yasko), A., P. Miller, J. Mueller, and H. Taber (1987) Bacterial uptake of Aminoglycoside Antibiotics. Microbiological Reviews 51:439-457.
  66. Arrow (Yasko), A. and H. Taber (1986) Streptomycin accumulation by Bacillus subtills requires both a membrane potential and cytochrome aa33. Antimicrobial Agents Chemotherapy 29: 143-148.
  67. Faletto, D.L., A. Arrow (Yasko) and I.G. Macara (1985) A very Early Decrease in Phosphatidylinositol Turnover Precedes the Decrease in c-myc Expression Accompanying Induction of Friend Erythroleukemia Cell Differentiation. Cell, 43:315.
Enable Javascript